| Name | Title | Contact Details |
|---|
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.
Paradox USA Inc is a Miami, FL-based company in the Business Services sector.
D.M. Bowman, Inc. is one of the leading providers in Business Services. It is based in Williamsport, MD. To find more information about D.M. Bowman, Inc., please visit www.dmbowman.com.
love to learn is a Salem, UT-based company in the Business Services sector.
Paragon Lodging is a property management company that offers luxury vacation homes in Breckenridge, Colorado. They provide customized travel services for guests and offer full-service concierge opportunities.